• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者合并曲霉病和毛霉菌病双重真菌感染致上颌窦炎:COVID-19 后首例报告。

Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.

机构信息

Department of Oral Pathology & Microbiology and Forensic Odontology. Laxmi bai institute of dental sciences and hospital, Patiala, Punjab, India.

Department of Oral and Maxillofacial surgery, Guru Nanak Dev Dental College and Research Institute, Sunam, Punjab, India.

出版信息

Acta Medica (Hradec Kralove). 2021;64(4):227-231. doi: 10.14712/18059694.2022.7.

DOI:10.14712/18059694.2022.7
PMID:35285446
Abstract

Coronavirus infectious disease-19 caused by Severe acute respiratory distress syndrome-coronavirus-2 has emerged to be an emergency global health crisis for more than a year. And, as the disease has spread, a number of new clinical features have been observed in these patients. Immunosuppression caused by this disease results in an exacerbation of pre-existing infections. While corticosteroids are considered a life-saving therapeutic intervention for this pandemic, they have proved to be a double-edged sword and their indiscriminate use has produced some deleterious results. Recently, in the backdrop of this expression, a notable rise in invasive fungal infections has been identified even in the post-remission phase. Mucormycosis, Aspergillosis, and Candidiasis are the three most common opportunistic fungal infections among those observed. COVID-19 patients with diabetes mellitus are already at a higher risk of developing such secondary infections due to impaired immunity. Here we present a rare case report of a 50-year old male diabetic mellitus patient diagnosed with dual fungal infections (Aspergillosis along with Mucormycosis) leading to maxillary sinusitis as a post-COVID manifestation. To our knowledge, this is the first such case reported till date.

摘要

由严重急性呼吸综合征冠状病毒 2 引起的新型冠状病毒传染病已持续超过一年,成为全球紧急卫生危机。随着疾病的传播,在这些患者中观察到了许多新的临床特征。这种疾病引起的免疫抑制会导致先前存在的感染恶化。尽管皮质类固醇被认为是治疗这种大流行的救命疗法,但事实证明它们是一把双刃剑,其不加区分的使用产生了一些有害的后果。最近,在这种情况下,即使在缓解后阶段,也发现侵袭性真菌感染明显增加。毛霉菌病、曲霉病和念珠菌病是观察到的三种最常见的机会性真菌感染。由于免疫受损,患有糖尿病的 COVID-19 患者已经处于发生此类继发感染的更高风险中。在这里,我们报告了一例罕见的 50 岁男性糖尿病患者的病例,该患者被诊断出患有双重真菌感染(曲霉病合并毛霉菌病),导致上颌窦炎作为 COVID 后的表现。据我们所知,这是迄今为止首例此类病例报告。

相似文献

1
Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.糖尿病患者合并曲霉病和毛霉菌病双重真菌感染致上颌窦炎:COVID-19 后首例报告。
Acta Medica (Hradec Kralove). 2021;64(4):227-231. doi: 10.14712/18059694.2022.7.
2
Mixed Infections (Mucormycosis, Actinomycosis and Candidiasis) Leading to Maxillary Osteomyelitis in a Diabetic Mellitus Patient in Post COVID Phase: First Case Report.混合感染(毛霉病、放线菌病和念珠菌病)导致 COVID 后阶段糖尿病患者上颌骨骨髓炎:首例病例报告。
Acta Medica (Hradec Kralove). 2021;64(4):218-223. doi: 10.14712/18059694.2022.5.
3
Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.墨西哥 COVID-19 后患者的上颌骨毛霉病和曲霉病:病例系列。
J Stomatol Oral Maxillofac Surg. 2024 Feb;125(1):101615. doi: 10.1016/j.jormas.2023.101615. Epub 2023 Aug 28.
4
Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.在一家三级保健医院中,COVID-19 后肺炎并发侵袭性毛霉病和曲霉病感染。
Med Mycol J. 2022;63(3):59-64. doi: 10.3314/mmj.21-00019.
5
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.新型冠状病毒肺炎相关混合霉菌感染:1例曲霉病和毛霉病病例报告及文献综述
J Mycol Med. 2022 Mar;32(1):101231. doi: 10.1016/j.mycmed.2021.101231. Epub 2021 Nov 26.
6
Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.冠状病毒病相关毛霉病的长期转归:来自印度的 1 年随访研究。
J Assoc Physicians India. 2024 Jun;72(6):44-48. doi: 10.59556/japi.72.0564.
7
[Mucormycosis of the face associated with aspergillosis in the diabetic patient. Diagnostic and therapeutic considerations].[糖尿病患者面部毛霉病合并曲霉病。诊断与治疗考量]
Ann Otolaryngol Chir Cervicofac. 1989;106(6):327-9.
8
COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.COVID-19 相关毛霉菌病 - “黑真菌”伴侵袭性曲霉菌病和放线菌感染:印度情况的 5 例系列病例。
Indian J Pathol Microbiol. 2023 Oct-Dec;66(4):823-828. doi: 10.4103/ijpm.ijpm_507_22.
9
Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome.COVID-19 相关急性呼吸窘迫综合征患者的急性侵袭性鼻眶脑毛霉病。
Ophthalmic Plast Reconstr Surg. 2021;37(2):e40-e80. doi: 10.1097/IOP.0000000000001889.
10
Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.COVID-19 患者的曲霉菌病和毛霉菌病:系统评价。
J Coll Physicians Surg Pak. 2022 May;32(5):639-645. doi: 10.29271/jcpsp.2022.05.639.